Search images on Google Product Monograph
Active Ingredients:
- octreotide (octreotide acetate), 30 MG/VIAL
DIN: 02239325
Dosage Form(s): POWDER FOR SUSPENSION, SUSTAINED-RELEASE
Route(s) of Administration: INTRAMUSCULAR
Schedule: Prescription
Company: NOVARTIS PHARMACEUTICALS CANADA INC – official site
ATC:
- H01 - PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES (ATC, WHO, Wiki)
- H01C - HYPOTHALAMIC HORMONES (ATC, WHO)
- H01CB - Antigrowth hormones (ATC, WHO)
- H01CB02 - OCTREOTIDE (WHO)
Reference brand drug: Sandostatin
Packaging:
- Package size unit: No information
- Package type: No information
- Package size: No information
- Product information: 2ML
Pharmaceutical standard: MFR
External Links for Sandostatin Lar:
Search on Google
Novartis Pharmaceuticals Canada Inc
Go to Novartis website to see drug product details. Sometimes you can find sandostatin lar photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.